If you are having trouble viewing this email, please click here.
Welcome to the Axtria Collective!
Generative AI is paving the way for a new era of innovation and efficiency across all industries. Our featured content in this edition is a Gartner report on how Generative AI brings new value to the life sciences industry.
This edition also includes a comprehensive guide on machine learning, articles on how AI can improve patient journeys and increase productivity, a podcast episode on building a commercial function for emerging pharma, and more.
Happy reading!
FEATURED CONTENT
Predicts 2024: Generative AI Brings New Value to Life Sciences
Generative AI is ushering in a wave of transformation in the life sciences industry. This report by Gartner highlights how AI can streamline processes, optimize sales strategies, and enhance customer engagement. Learn how virtual assistants with emotional intelligence are transforming interactions with patients, providers, and partners. Download the report now for a glimpse into the future of the life sciences.
KNOWLEDGE STREAM
Building a Commercial Function for Emerging Pharma - Challenges and Lessons
Matthew Bachman, Senior Director at Milestone Pharmaceuticals, discusses the intricacies of building a commercial function for an emerging pharma company. He shares his vision, a prioritization framework, and key takeaways from his journey.
INDUSTRY PRIMER
Machine Learning
If you're looking to leverage ML for real-time insights, this article is a must-read. Dive into the distinctions between AI, ML, and Deep Learning, and understand how ML works. Learn how to create good ML models, understand the applications of ML in healthcare, and more.
LEADER'S PERSPECTIVES
Data-driven Insights, Productization of Analytics and the Promise of Gen AI
In an interview with ETHealthworld, Jassi Chadha, CEO and President of Axtria, discusses Gen AI's potential to enhance productivity, analyze data, and reduce errors. He also discusses the importance of data-driven insights, scaling analytics through productization, and plans for Axtria's growth.
TIMELESS INSIGHTS
Empowering the Patient Journey with AI-Driven Outcomes
This article discusses how pharmaceutical companies can combine next-generation AI capabilities with advanced data science techniques to enhance patient experience. It highlights AI's potential in interpreting patient data for personalized care, reducing medical costs, and improving patient engagement through tailored messaging.
UPCOMING EVENTS
PMSA 2024 Annual Conference
Axtria is proud to announce that we are a Platinum Sponsor at the upcoming PMSA Annual Conference, which will be held from May 5 – 8, 2024, in Denver, CO, USA. Join us for interactive workshop and focus-group sessions with our experts, along with engaging podium and poster presentations. Stop by Booth 208 to hear how Axtria can help you unlock solutions for your commercialization lifecycle challenges.
ISPOR 2024
Axtria’s game-changing approach to integrated evidence generation will be the focus at ISPOR 2024, which will be held from May 5-8 in Atlanta, GA, USA. Our RWE and HEOR thought leaders will be available at Booth 407 to share pioneering insights and strategies in real-world evidence and health economics outcomes research.
NEWS CAPSULE
Axtria Took Center Stage at the PMSA 2024 Global Summit Debut in India
Leaders from Axtria delivered the keynote address, participated in multiple panel discussions, and delivered presentations at the Pharmaceutical Management Science Association’s (PMSA) 2024 Global Summit. The two-day summit held in New Delhi on March 7 & 8, PMSA’s first-ever in India, was themed "Evolution of Data, Analytics, and AI." Read More>>
Axtria Inc., 300 Connell Drive, Berkeley Heights, NJ 07922, USA
If you are having trouble viewing this email, please click here.
This email was sent to Sir / Ma'am by connect@axtria.com.To ensure delivery of emails to your inbox, please add connect@axtria.com to your address book or safe sender list. Please click here to unsubscribe or update your preferences for upcoming newsletters.